Disruption of p53 in human cancer cells alters the responses to therapeutic agents - Bunz,F.; Hwang,P.M.; Torrance,C.; Waldman,T.; Zhang,Y.; Dillehay,L.; Williams,J.; Lengauer,C.; Kinzler,K.W.; Vogelstein,B. (The Journal of Clinical Investigation, 1999)